# FDA OTHER_CORRESPONDENCE - Unknown Company - February 14, 2019

Source: https://www.keypedia.com/records/other_correspondence/unknown-company/fe3cbfae-2a82-40c7-bdc9-b0fdc02052b6

> FDA OTHER_CORRESPONDENCE for Unknown Company on February 14, 2019. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: OTHER_CORRESPONDENCE
- Inspection Date: 2019-02-14
- Product Type: Drugs
- Office Name: Division of Pharmaceutical Quality Operations I

## Related Documents

- [483 - 2011-05-05](https://www.keypedia.com/records/483/unknown-company/8f74a6dc-c0a5-4354-8036-3890202fc8eb)
- [RESUME - Unknown Date](https://www.keypedia.com/records/resume/unknown-company/f071af8e-ce6c-4c87-947b-39d97b8c2137)
- [483 - 2023-07-14](https://www.keypedia.com/records/483/unknown-company/ab0a6d0b-c0ca-4e02-82e2-ad2098b7fe12)
- [483 - 2017-08-09](https://www.keypedia.com/records/483/unknown-company/c9125a20-c458-41ce-a15c-b212897a235f)
- [483 - 2011-03-18](https://www.keypedia.com/records/483/unknown-company/da4f7d5a-691d-4aff-8e4f-02abadace162)

## Related Officers

- [Matthew J. Buderer](https://www.keypedia.com/people/matthew-j-buderer/10d81d0a-0e47-44d5-ab96-f1743c501ad1)
- [Katie Stabi](https://www.keypedia.com/people/katie-stabi/1bad7711-a5e1-45a7-a6fd-73b12b70799e)
- [Alvin Budeaer](https://www.keypedia.com/people/alvin-budeaer/2d05e484-887c-4a84-9e35-1f0da147d443)
- [Henry Enkelman](https://www.keypedia.com/people/henry-enkelman/2f39f529-b44c-4dc9-bed9-040a3c443f9c)
- [Kenneth E. Crawford III](https://www.keypedia.com/people/kenneth-e-crawford-iii/55b336d8-7094-49d3-8ae0-f8edfe9423c0)

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-i/6ded4818-ee3a-46a1-84c1-36de58502b02